The prevalence of extramedullary acute myeloid leukemia detected by <sup>18</sup>FDG-PET/CT: final results from the prospective PETAML trial.

导出 OA

翻译打印收藏纠错

第一作者： Friedrich,Stölzel

第一单位： Department of Internal Medicine I, University Hospital Carl Gustav Carus Dresden, Technische Universität Dresden, Dresden, Germany friedrich.stoelzel@uniklinikum-dresden.de.

作者： Friedrich,Stölzel ^[1] ; Tors,Lüer ^[2] ; Steffen,Löck ^[3] ; Stefani,Parmentier ^[4] ; Friederike,Kuithan ^[5] ; Michael,Kramer ^[2] ; Nael S,Alakel ^[2] ; Katja,Sockel ^[2] ; Franziska,Taube ^[2] ; Jan M,Middeke ^[2] ; Johannes,Schetelig ^[2] ; Christoph,Röllig ^[2] ; Tobias,Paulus ^[6] ; Jörg,Kotzerke ^[7] ; Gerhard,Ehninger ^[2] ; Martin,Bornhäuser ^[2] ; Markus,Schaich ^[8] ; Klaus,Zoephel ^[9]

作者单位： Department of Internal Medicine I, University Hospital Carl Gustav Carus Dresden, Technische Universität Dresden, Dresden, Germany friedrich.stoelzel@uniklinikum-dresden.de. ^[1] Department of Internal Medicine I, University Hospital Carl Gustav Carus Dresden, Technische Universität Dresden, Dresden, Germany. ^[2] OncoRay -National Center for Radiation Research in Oncology, University Hospital Carl Gustav Carus, Technische Universität Dresden, Helmholtz Zentrum, Dresden Rossendorf, Germany. ^[3] Department of Haematology and Oncology, Rems-Murr-Hospital, Winnenden, Germany. ^[4] Department of Pathology, University Hospital Carl Gustav Carus Dresden, Technische Universität Dresden, Dresden, Germany. ^[5] Department of Radiology, Städtisches Klinikum Dresden, Dresden, Germany. ^[6] Department of Nuclear Medicine, University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany. ^[7] National Center for Tumor Diseases NCT, Partner site Dresden, Dresden, Germany. ^[8] Department of Haematological Medicine, The Rayne Institute, King's College London, London, UK. ^[9]